anonymous
Guest
anonymous
Guest
Stock is tanking in late trading because of a competitor which they say is significantly going to give Vascepa a challenge. Say stock will decrease to 7 dollars a share
Just stop!!
Then why is the stock down 16% today. WTFCompetitor is 4 years from challenging.
Understand what you are selling! EPA greater than the drugs with DHA...which don’t even have a CVOT trial. That was a hit piece to cover short sell stock.